Browse

Explore conditions, clinical trials, and the organisations running them.

Epstein-Barr virus-associated lymphoproliferative disorder

A range of lymphoproliferative diseases characterized by uncontrolled proliferation of B cells, T cells, or NK cells infected with Epstein-Barr virus. Depending on host immunity and viral factors, viral persistence in host cells can induce lymphoproliferation with a diverse clinical spectrum ranging from simple reactive hyperplasia to aggressive lymphoma/leukemia with unique clinical and pathological presentations.

22 trials tagged with this condition →

Hodgkins lymphoma 262 trials · 326 incl. sub-types Sub-types →
Burkitt lymphoma 220 trials Sub-types →
Primary central nervous system lymphoma 92 trials · 103 incl. sub-types Sub-types →
Extranodal nasal NK/T cell lymphoma 51 trials
Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly 23 trials
Plasmablastic lymphoma 20 trials
Primary effusion lymphoma 18 trials
Lymphomatoid granulomatosis 3 trials · 7 incl. sub-types Sub-types →
Diffuse large B-cell lymphoma with chronic inflammation 3 trials
Hydroa vacciniforme-like lymphoma 3 trials
Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood 2 trials